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Introduction:    
Leishmaniasis is a protozoan disease that is common in tropical areas of the globe. 
Around the world this disease is transmitted from different hosts by various sand-fly species. The 
most prevalent countries for any type of leishmaniasis are Brazil, India, and Ethiopia1.  There are 
three presentations of the disease seen around the world: visceral, mucosal, and cutaneous. 
Specifically, in the Central American countries of Nicaragua and Costa Rica 1,000-4,999 cases 
of the cutaneous form present each year1.  The types of protozoa seen in this disease are 
classified into new-world and old-world species. The old-world species are typically found in 
Africa, Asia, and Europe while the new-world are seen in the Americas2.  Depending on the 
specific subspecies of leishmaniasis an individual is likely to develop different presentations of 
leishmaniasis3.  There are currently about 12 million people afflicted with this disease while 1-2 
million cases are expected to develop each year3. Leishmaniasis has been seen in 89 countries 
around the world and because it occurs more frequently in rural and impoverished areas, there is 
a lack of affordable treatments. 
In order to decrease the prevalence and sequelae of cutaneous leishmaniasis (CL) the 
world each step of the medical process must be evaluated. This paper intends to evaluate the 
methods of prevention in rural and urban areas, the diagnostic procedures and their necessity, 
and the various treatment options to properly cure leishmaniasis, dependent on the species.  A 
literature review using online articles and in-person interviews from individuals native to rural 
areas of Costa Rica will be utilized to compound information. It is the goal of this paper to 
identify a most appropriate plan for the prevention methods and treatment of individuals with 
CL. 
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Background: 
Leishmaniasis can be caused by more than twenty different species of protozoa and that 
leads to various presentations of the disease1.  As previously stated there are three main forms of 
leishmaniasis in visceral, mucosal and cutaneous forms and within those there are further 
subcategories. While visceral is the deadliest form of the disease, cutaneous has the most obvious 
presentation to patients and providers alike. CL can be further broken down into localized CL, 
disseminated CL, cutaneous-chondral, and muco-cutaneous leishmaniasis3.  Apart from muco-
cutaneous these forms can be identified primarily by visual appearance of the lesion. How CL 
presents is based on a few different factors including, the species of protozoan infecting the host, 
the immunologic ability of the host, and access to treatment.  The longer delay to treatment and a 
decreased immune capability can lead to the more systemic forms of CL, those being 
disseminated CL, and the sequela form of muco-cutaneous3. 
It is important to understand the life cycle of protozoa to understand how it is transmitted 
and ultimately how it can be diagnosed. The protozoa begin in a form called amastigote, which is 
non-flagellated and is often found within the white blood cells of the infected host3. The 
amastigotes are absorbed by the initial bite of a sand-fly and within this vector the amastigote 
turns into the flagellated promastigote. The promastigote starts as procyclic and then metacyclic, 
which is the infectious form of the disease3. Due to the life cycle of the protozoa there is an 
incubation period of the disease that can vary from weeks to years. It is because of this fact that 
the infected host may appear asymptomatic for a long period of time before knowing they have 
been infected with leishmaniasis.  It is also possible for the disease to recur in months or years to 
come because of the potential latency of the protozoa3. 
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The disease is transmitted by sand-flies of many species but most commonly by the 
species Phlebotomus4. These sand-flies are known to bite various hosts including humans, 
domestic animals, and wild mammals and reptiles3. Since there are many opportunistic hosts for 
CL the prevention of sand-flies and their bites can be difficult. Urban environments are usually 
not conducive to sand-fly habitats, however with continued deforestation of tropical areas the 
flies that live there may migrate to more populated areas. Another factor to consider for 
transmission of disease is travelers, both in and out of the country. Individuals that visit the 
forests of Central America, are bitten, and return home can increase the risk of spreading the 
disease to others.  Though the number of flies that can behave as vectors decreases upon return to 
urban areas there may be enough insects around to spread the protozoa. 
Prevention methods in around the world can vary based on the amount of money one is 
willing to spend. There currently is not a vaccine available for leishmanial diseases, however 
there are plans for development of one in the future by the WHO3. The goal of this vaccine is to 
prevent the necessity for expensive treatments and medications. The current recommended 
prevention methods include: wearing long sleeves, using insect repellents with DEET, wearing 
clothes that are infused with permethrin, and using fine mesh netting2.  While wearing long 
sleeves seems simplistic the hot weather and incidence of outdoor work makes this first 
recommendation quite difficult to manage.  Using insect repellent with DEET is shown to reduce 
the risk of infection, though which concentration of DEET to use is up to debate2. Mesh nettings 
are commonly used by indigenous and rural communities to prevent mosquitos and other insects 
from biting while they sleep, though the efficacy of these nettings for sand-flies is possibly 
decreased due to the smaller size of the sand-fly2.  
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Despite the preventative measures used, more than 1,000 individuals in Costa Rica and 
Nicaragua develop CL each year1. For patients of rural communities, it can be difficult to reach a 
medical professional and if the lesion isn’t bothersome, they may not consider it necessary. For 
those that do seek attention, the lesion caused by CL may appear differently depending on what 
stage it is in.  The infection normally begins as a papule or nodule which over time develops into 
a painless ulcerative lesion. This lesion is noted to have raised margins, a central granulomatous 
base and possibly a serous discharge.  The ulceration may also be associated with localized 
lymphadenopathy. The most common locations for injury are the sites that are commonly 
exposed to sand-fly bites: the face, ears, and extremities5. It is important for providers to keep in 
mind how the four types of CL may present differently. The localized form will have one lesion, 
but there also may be multiple localized CL on one individual. The chondral form is any lesion 
that affects the ears. The disseminated form will have multiple lesions that are all developing at a 
similar rate and may appear in all areas of the skin but should not affect internal organs. Finally, 
the muco-cutaneous form, another systemic type, will have involvement of one or more mucous 
membranes, typically the nose or the mouth, along with an ulcer that resembles the localized or 
disseminated types3. Because the lesions develop at different rates it is important for providers to 
remember to do thorough skin and mucous membrane checks for every patient that CL is 
suspected in. 
There are a few different lesions that may look similar to CL including pyoderma 
gangrenosum, Buruli ulcers, and chronic tropical ulcers caused by Vincent’s organisms6.  To 
confirm the diagnosis of CL there are two diagnostic test that are commonly performed. The first 
test is a biopsy of the infected skin which is then observed by light microscopy.  If CL is present 
in large enough numbers a visual representation of the amastigotes should be visible5.  If the 
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protozoan yield of amastigotes is too low, the “gold standard” method of real-time PCR can be 
used.  Through PCR the exact species of leishmaniasis can be identified and a treatment plan can 
be decided upon4.  There are many species of leishmaniasis that can occur in the “new-world.” 
The main species include Leishmania mexicana and Leishmania viannia, which includes 
Leishmania braziliensis and Leishmania panamensis5.  L. mexicana is typically associated with 
localized cutaneous forms of CL compared the L. viannia species that can be associated with 
muco-cutaneous presentations and more systemic illnesses3. 
Treatments may not be necessary for individuals with CL depending on certain 
requirements.  The guidelines for treatment vary depending on the source but most agree that CL 
with dissemination, mucosal involvement, or in locations on the face, ears, or joints should be 
treated7. According to a different source, treatments should be made available to those with 
lesions over four cm, three or more active lesions, and for those that developed CL in South 
America5. For patients without access to treatment, or do not desire it, as long as the individual 
was not in an immunocompromised state the wound should resolve on its own.  The rate of 
which the wound will heal on its own depends on the species as well.  If L. mexicana is the 
source of the lesion it should heal in three to nine months, however if one of the L. viannia 
species are causing the infection the wound may take from six to fifteen months to heal on its 
own2.   
If treatment is desired there are many different treatment options available including IV 
pentavalent antimony, IV liposomal amphotericin B, miltefosine, ketoconazole, fluconazole, 
itraconazole, topical paramomycin and gentamicin, cryotherapy, and thermotherapy5.  Though 
more expensive, the “gold standard” treatment is intravenous pentavalent antimony compound of 
which there are two, sodium stibogluconate and meglumine antimoniate3.  These treatments are 
Nobody Likes Flies  7 
considered anti-leishmanial.  They have been used for treatment for about half a century and can 
cause many adverse effects8.  Some of these adverse effects include local irritation, anorexia, 
myalgia, arthralgia, nausea, vomiting, and EKG changes3. Due to incidence of these side effects 
many individuals may not be able to tolerate the full treatment plan of twenty-one days.  
Currently, of the two, only sodium stibogluconate has a generic form, which leads to it being the 
drug of choice in for many2. 
 The choice of alternate systemic therapy often depends on the species of leishmaniasis 
causing infection. Ketoconazole has been used to cure L. panamensis, while IV liposomal 
amphotericin B is used for L. braziliensis and L. chagasi infantum9.  Miltefosine has been studied 
with a wide variety of species including L. braziliensis, tropica, and infantum chagasi9.  
Liposomal amphotericin is the only medication that is safe for pregnancy but is still expensive 
and has side effects that include fever, chills, renal insufficiency, hypokalemia, and anemia5. 
Miltefosine was first used as a chemotherapy agent in the 1980’s but is generally well tolerated.  
It has been known to cause some nausea, vomiting, headaches, and diarrhea but those symptoms 
typically abate after the first week of treatment5. 
 In one case trial ketoconazole has an efficacy rate of 76% (N=21) compared to sodium 
stibogluconate which only had a cure rate of 68% (N=19)9.  In a case report by Dr. Abadir et al. 
itraconazole was stated to not work for CL and sodium stibogluconate was utilized instead2. In a 
review article by Torres-Guerrero et al. it was suggested that ketoconazole or itraconazole are 
more efficacious than fluconazole3. However, in a third article detailing CL treatment practices 
in the US by Dr. Eiras et al. ketoconazole or high doses of fluconazole are thought to be useful5. 
Due to these contradicting articles ketoconazole seems to be the most effective of the azole 
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agents, while the efficacy of fluconazole and itraconazole is debatable2,3,5.  As is typical with 
antifungal agents, common adverse effects include GI symptoms and hepatotoxicity5.   
 Topical antibiotics like paramomycin have varying efficacy rates with reports anywhere 
from 4% - 93% being observed10.  It has been demonstrated that though the efficacy varies, 
paramomycin alone is still better than placebo and even greater cure rates occur when 
paramomycin is combine with methylbenzethonium chloride (MBCL) or gentamicin sulfate10,11.  
Though generally safe for local use, a few adverse effects include application site erythema, 
edema, and pain11. These reactions are decreased by the addition of gentamicin, but more 
commonly seen with the MBCL formula10,11. 
 Finally, for individuals that seek the more conservative route or cannot tolerate 
medications, cryotherapy and thermotherapy have been used advance the healing process.  
Cryotherapy is a common treatment for localized lesions in the US, by way of liquid nitrogen6. 
As a conservative method of thermotherapy, objects such as silver nitrate, brown sugar oil, 
candle wax, and heated metal objects have been applied to lesions with reported healing of the 
wound, though these reports are from solely by word of mouth without any proof of evidence12. 
In other parts of the world, studies focused on more controlled methods including hot baths, laser 
therapy and infrared light were utilized, but one of the most studied methods of heating is seen 
by using radiofrequency therapy, which is the use of a device to heat a localized area with radio 
waves12.  In a study performed in 2015 in Brazil 13 out of 15 patients had complete cure of CL 3 
months after treatment12. The side effects experienced by radiofrequency therapy include pain, 
itching, burning, and possibly blisters12.   
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Methods: 
 Research on leishmaniasis as a whole was performed on international informative 
websites run by the WHO and the CDC.  From there specific information about CL was selected 
and used for more advanced searches. The research database PubMed was used to find two 
generalized articles about CL with points detailing prevention, history and physical exam, 
diagnosis, and treatment.  Using references from those articles and further details about the 
specific treatments, another article was discovered with information on diagnostic procedures 
and seven more were found describing various treatment practices. 
 In-person interviews were conducted as part of a large group in Costa Rica with various 
individuals.  Information was gathered from individuals from the Longo Mai community and a 
woman from the BriBri tribe.  The woman from the BriBri tribe was a representative that was 
familiar with using natural herbs and remedies to avoid insects and thwart diseases.  One 
individual from Longo Mai was a farmer with a wealth of information on how the crops were 
treated and cared for.  The second individual was a leader of Longo Mai and demonstrated which 
natural remedies were used and for what purpose. Though none of these individuals were 
familiar with leishmaniasis by name they did recognize that diseases are commonly caused by 
flies and mosquitos and that their natural cocktails are effective for preventative measures.  
Further questions about treatments for these conditions was not requested due to the fact that 
leishmaniasis could not be identified specifically. 
Discussion: 
General types of prevention methods were found by online research and interviews with 
people from rural areas of Costa Rica. Specific information on the prevention styles listed were 
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not detailed in the articles referenced by this paper and did not appear after thorough search 
requests.  According to a woman from the Costa Rican indigenous tribe, BriBri, a common way 
to avoid insect bites is to use a form of fumigation around communal areas. She stated that a 
combination of bitter plants, such as lemongrass, are boiled in a pot. The steam that is released 
from the mixture is released around doors and windows to keep insects away.   
A similar statement was shared by individuals from the rural Longo Mai community in 
Costa Rica.  They also have mentioned using plants to ward away bothersome pests. Like the 
BriBri tribe, the field workers use bitter plant cocktails to keep insects away from crops and 
themselves.  A farmer from Longo Mai discussed three methods for dispersing the repellent. The 
first method, and the simplest, is by simply dipping a brush into the repellent and spreading the 
bitter water amongst the leaves of the plant.  He mentioned that this style is the cheapest, but it 
also takes a long time to spread the mixture.  The second style is by use of steam, similar to the 
BriBri tribe and the third way is through mixing the repellent directly into the soil.  It was noted 
that the steam method is typically the most effective, but also takes more effort to boil the water 
and buy supplies for dispersing the steam.  It was also mentioned by a leader of the Longo Mai 
community that citronella is commonly grown around houses to keep mosquitos and flies away.  
This material gathered from citizens of less inhabited areas of Costa Rica provided details 
on the distribution of natural repellents, but the exact composition was not discussed due to 
language barrier, lack of time, and the informants’ inability to reprise the details.  The use of any 
preventative measure is suggested by professionals, but the actual use of these techniques is 
probably more limited than it seems. One factor that obstructs prevention is the cost of the 
method like permethrin infused clothing and insect repellent containing DEET. It is also 
important to consider the comfortability of the individual when wearing long sleeves in the heat 
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of Central America.  Another barrier to prevention is knowledge of the method, for example how 
to concoct a solution for natural repellent or which type of netting can best prevent insect bites. 
 Though the mainstay for diagnosis of CL is PCR, there is a challenge for some 
individuals in Costa Rica to get to a clinic or to pay for a lesion in which may heal on its own. 
Since there is a chance for resolution of the disease, it is easy to see how patients with CL would 
choose not to get an official diagnosis by PCR or biopsy.  It may be possible, with the right 
information, for the individual to identify a bite by a sand-fly and how the lesion could present if 
infected, though the exact species of sand-fly and species of leishmaniasis would not be possible.  
Despite the barriers to availability of diagnosis it is still recommended that individuals with 
concerning lesions seek medical attention. Though rare in Central America, it is fairly common 
for species of leishmaniasis in Brazil to present in the visceral form which is deadly3.  
 Deciding on a treatment option may be difficult or simplistic depending on the 
individual’s stance on getting treated. If the patient chooses not to utilize medical treatment their 
options are limited to cryotherapy, thermotherapy, or waiting for the lesion to heal on its own.  
Waiting for a lesion to heal could take months to years and even if one lesion does heal another 
may recur3.  This is still going to be a popular option for those that aren’t bothered by a scarred 
appearance on their skin.  Finding an effective method for cryotherapy would remain quite 
difficult in rural regions of Central America, though liquid nitrogen may be available for use in 
larger cities.  The uses of thermotherapy in rural areas around the world are likely to be used in 
Central American countries as well, especially non-specific styles such as hot baths, candle wax, 
and heated metals.  One issue with the study of radiofrequency therapy to heal CL ulcers is the 
relatively small patient population.  Another problem with the study itself is that the way 
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radiofrequency is used is not described and may differ depending on the provider that is utilizing 
the therapy. 
 Pentavalent antimony compounds are noted to be available worldwide and used 
frequently as the mainstay for CL.  Which drug is available depends on your region but the 
efficacy of both sodium stibogluconate and meglumine antimoniate are noted to be higher than 
every other treatment method available2,3,5,6. According to a case study and review by Dr. Abadir 
et al. the efficacy of either pentavalent antimony is equivocal and the cure rate for first time use 
was 76.5%, with a second dose the cure rate increased to 91.5%2.  Since these medications are 
the gold standard they are studied in the context of CL more often and compared to other 
medications more frequently.  There is one study in which another medication has a higher 
efficacy, ketoconazole had 8% higher cure rate when compared to sodium stibogluconate9.  The 
issue with this study is that each trial had very small population sizes and it is commonly known 
that the pentavalent antimony treatment plan requires a more rigorous adherence with more 
difficult side effects3,9.  
 Though the sample size was small ketoconazole did prove to be comparably efficacious 
to the gold standard.  Other studies agree that ketoconazole may be a good alternative to 
antimonial compounds when looking at cost or availability3,5.  A provider should remain cautious 
of the use of itraconazole and fluconazole due to conflicting information.  There may be inherent 
bias in the authors of these articles demonstrating which antifungal treatment works best, 
especially since efficacy rates for the azole groups are not mentioned.  It would be an interesting 
study for future researchers to compare the cure rates of each of these three antifungals in 
treating CL. 
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 Liposomal amphotericin B and miltefosine are most likely not used frequently in Central 
America due to their high cost12.  These medications appear to be fairly effective in treating CL 
when paired with a specific species that is likely to susceptible to it.  In one study a cure rate was 
achievable for every patient that completed follow-up, however the reason for patients dropping 
out is not listed9.  The patients may have dropped out due to the nephrotoxicity of amphotericin 
B or simply because they no longer wished to be a part of the study.  Overall these medications 
should be considered for treatment if the individual can afford to pay it, if pentavalent antimony 
is unavailable, or if a patient is pregnant (amphotericin specifically).   
 Topical antibiotics should also be used cautiously with their varying efficacy ratings10.  
Though they are demonstrated to be better than placebo, the provider should not recommend 
these medications without consideration of resistance.  A combination with paramomycin is seen 
to have greater cure rates with either MBCL or gentamicin sulfate most likely due to the 
increased coverage of infectious agent11,12.  Since the application of the treatment is more 
simplistic and cheaper than other medications, it may be used more commonly in areas with 
limited access to medical care. 
Conclusion: 
 Overall cutaneous leishmaniasis is a disease that can be disfiguring and disrupting to 
individuals across the world. Though it may be difficult to access information for those in rural 
communities in Central America it is important for providers to provide information in an 
attempt to spread details about sand-fly bites and CL.  Preventative guidelines should be 
addressed primarily in an effort to decrease the incidence of the disease.  Hopefully the 
development of antileishmanial vaccines by the WHO will be supported and completed in the 
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near future, but these vaccines should also be made available, at no cost, to anyone in an endemic 
area.   
 If any treatment is possible, based on the research above, the gold standard medication of 
a pentavalent antimony compound should be the first choice.  All of the medications included in 
this article have been compared to at most two other medications.  A useful research topic for the 
future would be a collective study comparing the efficacy of multiple different medications for 
CL.  Another topic for research would be the development of a new pentavalent antimony 
compound.  Little is currently known about the structures of these compounds and if more 
information can be gathered then perhaps a new medication could be developed with an 
increased efficacy and a decreased risk for side effects.  Though these thoughts may be idealistic, 
it is important to continue education of the general population and research on a disease that 
afflicts so many individuals worldwide and maybe, someday, leishmaniasis will become a 
disease of the past. 
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